NCT03892850

Brief Summary

Objective: To compare the efficacy/effectiveness of pharmacological nurse prescription with medical prescription in patients attended in a primary care center for minor acute health problems. Scope of the study: Multicenter study, with the participation of 8 primary care centers of Catalonia. Methodology: Randomized blind clinical trial, with experimental group receiving pharmacological nurse prescription and a control group receiving medical prescription. Subjects are individuals who request a same day consultation for minor acute pathologies and meet the selection criteria, with random assignment of 374 subjects, 187 per group. The efficacy/effectiveness of the prescribed treatment will be considered as a no re-attendance during the following 72h and will be completed with the variables: information and knowledge of the treatment, adverse effects, compliance, satisfaction level and resolution of the health problem. The data collection is done 10 days after the visit by an ad-hoc telephone questionnaire of 11 items, previously tested. The analysis is done using the SPSS software version 21.0, obtaining data of descriptive, multivariate and inferential statistics. Implications for practice: To evidence the equivalence of pharmacological nurse prescription with medical prescription for minor acute health problems

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
374

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 18, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 27, 2019

Completed
5 days until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
Last Updated

March 29, 2019

Status Verified

March 1, 2019

Enrollment Period

7 months

First QC Date

March 18, 2019

Last Update Submit

March 27, 2019

Conditions

Keywords

PrescriptionsNursesPrimary Health CareAcute Disease

Outcome Measures

Primary Outcomes (1)

  • no re-attendance during the following 72 hours

    Options: Yes / No

    During next 72 hours

Secondary Outcomes (5)

  • Level of information and knowledge of the treatment

    after 10 days

  • adverse effects

    after 10 days

  • satisfaction level

    after 10 days

  • resolution of the health problem

    after 10 days

  • compliance

    after 10 days

Study Arms (2)

nurse prescription

EXPERIMENTAL

experimental group receiving pharmacological nurse prescription

Behavioral: Nurse prescription

medical prescription

ACTIVE COMPARATOR

control group receiving medical prescription

Behavioral: Medical prescription

Interventions

Pharmacological nurse prescription. Subjects are individuals who request a same day consultation for minor acute pathologies and meet the selection criteria

nurse prescription

Pharmacological medical prescription. Subjects are individuals who request a same day consultation for minor acute pathologies and meet the selection criteria

medical prescription

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Contusion
  • Diarrhea / vomit
  • Fever without focality
  • Flu
  • Urinary distress
  • Odinophagy
  • Toothache
  • Skin Bite
  • Upper respiratory symptoms
  • Ankle twist

You may not qualify if:

  • Language barrier
  • Cognitive deterioration
  • Sensory deficit
  • Pregnancy
  • Immunosuppression
  • Neoplasia in the last 5 years
  • Does not participate / Does not sign consent
  • Breastfeeding period
  • Reconsult
  • Resides outside of Spain
  • Treatment with glucocorticoids in the last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Acute Disease

Interventions

Prescriptions

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Pharmaceutical ServicesHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Sonia Fernandez Molero, Sonia

    Institut Universitari d'Investigació en Atenció Primària IDIAP Jordi Gol

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sonia Fernandez Molero, Nurse

CONTACT

Andres Baiget Ortega

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 18, 2019

First Posted

March 27, 2019

Study Start

April 1, 2019

Primary Completion

October 31, 2019

Study Completion

November 30, 2019

Last Updated

March 29, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share